13.11.2007 21:10:00

Accelrys to Offer Free Version of its Scientific Operating Platform to Academic Researchers

Accelrys, Inc. (NASDAQ:ACCL), a leading provider of scientific business intelligence solutions, announced the release of SciTegic Pipeline Pilot™ Student Edition software, a free stand-alone version of its scientific operating platform. SciTegic Pipeline Pilot Student Edition will enable academic researchers to create scientific software applications, integrate their scientific code and share their innovations within the academic community and with the commercial scientific community. Accelrys will host a free library on its community web site to promote the sharing of scientific innovation between academia and industry. The Student Edition comes with free component collections for statistics, reporting, and data and application integration. Academics can also select from Accelrys’ scientific collections in chemistry, sequence analysis, and gene expression to support specific research efforts. "The broad availability of SciTegic Pipeline Pilot Student Edition will foster scientific exchange and collaboration. Commercial users of SciTegic Pipeline Pilot will get convenient access to an unparalleled amount of cutting edge science from academic researchers,” said Mark Emkjer, President and Chief Executive Officer of Accelrys. "Accelrys' release of SciTegic Pipeline Pilot Student Edition is great news for drug discovery in academia and industry. Universities can now benefit from the industry standard workflow tool and industry can gain from the sharing of innovative new protocols from academia. An interoperable informatics platform is exactly what is needed if we want to share knowledge and improve everyone’s drug discovery productivity,” said Professor Andrew Hopkins, FRSC (formally with Pfizer), Scottish Universities Life Sciences Alliance Professor of Translational Biology and Chair of Chemical Informatics, University of Dundee, Scotland, UK. "The release of SciTegic Pipeline Pilot Student Edition to the academic community will be a boon for cheminformatics and bioinformatics research. Accelrys’ scientific operating platform has revolutionized the way that scientific computing gets done in the pharmaceutical industry, and I believe it can have a similar effect in academia. I hope this move will spur a new wave of innovation, enabling research that uses tools from different domains and disciplines and encouraging academic researchers to publish their code as web services," said David Wild, Assistant Professor and Associate Director of Cheminformatics, Indiana University. SciTegic Pipeline Pilot is used by over 300 companies worldwide to streamline the integration and analysis of the vast quantities of data flooding the research and development informatics world. The software allows researchers to graphically compose data processing workflows, known as protocols, using hundreds of different configurable components for operations such as data retrieval and manipulation, property calculations, computational filtering, and reporting. Integrated technologies are also available from over 30 third-party software companies that are members of the Accelrys Independent Software Vendor program, giving SciTegic Pipeline Pilot users access to a wide array of additional tools. For more information and terms and conditions for SciTegic Pipeline Pilot Student Edition, please visit http://www.accelrys.com/products/scitegic/pp-student/index.html today. About Accelrys, Inc. Accelrys develops and commercializes scientific business intelligence software for the integration, mining, analysis, modeling and simulation, management and interactive reporting of scientific data. Our solutions are used by biologists, chemists, materials scientists, and information technology professionals for product design as well as drug discovery and development. Our technology and services are designed to meet the needs of today’s leading research and development organizations including leading commercial, government and academic organizations. Many of the largest pharmaceutical, biotechnology, chemical, and petroleum companies worldwide use our solutions. Accelrys is headquartered in San Diego, California. For more information about Accelrys, visit its website at http://www.accelrys.com/ Forward-Looking Statements This press release contains forward-looking statements. Such statements, including statements relating to SciTegic Pipeline Pilot Student Edition, including its features and potential demand therefore, are subject to risks and uncertainties including, but not limited to, the risks that SciTegic Pipeline Pilot Student Edition will not successfully include all features described herein or demand relating to SciTegic Pipeline Pilot Student Edition, and potential resulting decrease in demand and revenue from the academic community for the commercial version, and other risks and uncertainties described in documents Accelrys has filed with the Securities and Exchange Commission, including its most recent report on Form 10-K and any subsequent interim filings. All forward-looking statements in this document are qualified entirely by the cautionary statements included in this document and such filings. These risks and uncertainties could cause actual results to differ materially from results expressed or implied by forward-looking statements contained in this document. These forward-looking statements speak only as of the date of this document. Accelrys disclaims any intent or obligation to publicly update or revise any forward-looking statements contained herein to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu Accelrys Inc Cash Settlement At USD 12.50 A Shmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Accelrys Inc Cash Settlement At USD 12.50 A Shmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 19 478,88 -0,06%